Systematic review of machine learning in the pharmaceutical

When it comes to machine learning effectiveness, more data almost always yields better results—and the healthcare sector is sitting on a data goldmine. While conducting a systematic review, many pharma companies estimate that big data and machine learning in pharma industries could generate more value and profit. It is based on, optimized innovation, improved research/clinical trials, better decision-making and new tool creation for physicians, consumers, insurers, and regulators.